Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice

Chronic infection with the hepatitis B virus (HBV) is a leading causes of liver cirrhosis and hepatocellular carcinoma. However, managing HBV treatments is challenging due to the lack of effective monotherapy. Here, we present two combination approaches, both of which aim to target and enhance the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Ruoyao, Cao, Jiali, Wu, Yangtao, Lei, Xing, He, Jinhang, Zhang, Liang, Fu, Rao, Chen, Feng, Wang, Yingbin, Zhang, Tianying, Xia, Ningshao, Yuan, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196021/
https://www.ncbi.nlm.nih.gov/pubmed/37213494
http://dx.doi.org/10.3389/fmicb.2023.1173061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196021/
https://www.ncbi.nlm.nih.gov/pubmed/37213494
http://dx.doi.org/10.3389/fmicb.2023.1173061

Ejemplares similares